Cargando…
Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients
Imatinib mesylate (IM) has dramatically improved the outcomes of gastrointestinal stromal tumor (GIST) patients. However, the clinical responses of IM may considerably vary among single individuals. This study aimed to investigate the influences of genetic polymorphisms of drug-metabolizing enzyme (...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372619/ https://www.ncbi.nlm.nih.gov/pubmed/28335376 http://dx.doi.org/10.3390/ijms18030603 |
_version_ | 1782518657009582080 |
---|---|
author | Liu, Jing Chen, Zhiyu Chen, Hanmei Hou, Yingyong Lu, Weiqi He, Junyi Tong, Hanxing Zhou, Yuhong Cai, Weimin |
author_facet | Liu, Jing Chen, Zhiyu Chen, Hanmei Hou, Yingyong Lu, Weiqi He, Junyi Tong, Hanxing Zhou, Yuhong Cai, Weimin |
author_sort | Liu, Jing |
collection | PubMed |
description | Imatinib mesylate (IM) has dramatically improved the outcomes of gastrointestinal stromal tumor (GIST) patients. However, the clinical responses of IM may considerably vary among single individuals. This study aimed to investigate the influences of genetic polymorphisms of drug-metabolizing enzyme (CYP3A4), transporters (ABCB1, ABCG2), and nuclear receptor (Pregnane X Receptor (PXR, encoded by NR1I2)) on IM plasma levels and related adverse reactions in Chinese GIST patients. A total of 68 Chinese GIST patients who have received IM 300–600 mg/day were genotyped for six single nucleotide polymorphisms (SNPs) (CYP3A4 rs2242480; ABCB1 rs1045642; ABCG2 rs2231137; NRI12 rs3814055, rs6785049, rs2276706), and the steady-state IM trough plasma concentrations were measured by a validated HPLC method. There were statistically significant variances in the steady-state IM trough plasma concentrations (from 272.22 to 4365.96 ng/mL). Subjects of GG in rs2242480, T allele carriers in rs1045642 and CC in rs3814055 had significantly higher steady-state IM dose-adjusted trough plasma concentrations. Subjects of CC in rs3814055 had significantly higher incidence rate of edema. The genetic polymorphisms of rs2242480, rs1045642, rs3814055 were significantly associated with IM plasma levels, and the genetic variations of rs3814055 were significantly associated with the incidence rate of edema in Chinese GIST patients. The current results may serve as valuable fundamental knowledge for IM therapy in Chinese GIST patients. |
format | Online Article Text |
id | pubmed-5372619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-53726192017-04-10 Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients Liu, Jing Chen, Zhiyu Chen, Hanmei Hou, Yingyong Lu, Weiqi He, Junyi Tong, Hanxing Zhou, Yuhong Cai, Weimin Int J Mol Sci Article Imatinib mesylate (IM) has dramatically improved the outcomes of gastrointestinal stromal tumor (GIST) patients. However, the clinical responses of IM may considerably vary among single individuals. This study aimed to investigate the influences of genetic polymorphisms of drug-metabolizing enzyme (CYP3A4), transporters (ABCB1, ABCG2), and nuclear receptor (Pregnane X Receptor (PXR, encoded by NR1I2)) on IM plasma levels and related adverse reactions in Chinese GIST patients. A total of 68 Chinese GIST patients who have received IM 300–600 mg/day were genotyped for six single nucleotide polymorphisms (SNPs) (CYP3A4 rs2242480; ABCB1 rs1045642; ABCG2 rs2231137; NRI12 rs3814055, rs6785049, rs2276706), and the steady-state IM trough plasma concentrations were measured by a validated HPLC method. There were statistically significant variances in the steady-state IM trough plasma concentrations (from 272.22 to 4365.96 ng/mL). Subjects of GG in rs2242480, T allele carriers in rs1045642 and CC in rs3814055 had significantly higher steady-state IM dose-adjusted trough plasma concentrations. Subjects of CC in rs3814055 had significantly higher incidence rate of edema. The genetic polymorphisms of rs2242480, rs1045642, rs3814055 were significantly associated with IM plasma levels, and the genetic variations of rs3814055 were significantly associated with the incidence rate of edema in Chinese GIST patients. The current results may serve as valuable fundamental knowledge for IM therapy in Chinese GIST patients. MDPI 2017-03-13 /pmc/articles/PMC5372619/ /pubmed/28335376 http://dx.doi.org/10.3390/ijms18030603 Text en © 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Liu, Jing Chen, Zhiyu Chen, Hanmei Hou, Yingyong Lu, Weiqi He, Junyi Tong, Hanxing Zhou, Yuhong Cai, Weimin Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients |
title | Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients |
title_full | Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients |
title_fullStr | Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients |
title_full_unstemmed | Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients |
title_short | Genetic Polymorphisms Contribute to the Individual Variations of Imatinib Mesylate Plasma Levels and Adverse Reactions in Chinese GIST Patients |
title_sort | genetic polymorphisms contribute to the individual variations of imatinib mesylate plasma levels and adverse reactions in chinese gist patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372619/ https://www.ncbi.nlm.nih.gov/pubmed/28335376 http://dx.doi.org/10.3390/ijms18030603 |
work_keys_str_mv | AT liujing geneticpolymorphismscontributetotheindividualvariationsofimatinibmesylateplasmalevelsandadversereactionsinchinesegistpatients AT chenzhiyu geneticpolymorphismscontributetotheindividualvariationsofimatinibmesylateplasmalevelsandadversereactionsinchinesegistpatients AT chenhanmei geneticpolymorphismscontributetotheindividualvariationsofimatinibmesylateplasmalevelsandadversereactionsinchinesegistpatients AT houyingyong geneticpolymorphismscontributetotheindividualvariationsofimatinibmesylateplasmalevelsandadversereactionsinchinesegistpatients AT luweiqi geneticpolymorphismscontributetotheindividualvariationsofimatinibmesylateplasmalevelsandadversereactionsinchinesegistpatients AT hejunyi geneticpolymorphismscontributetotheindividualvariationsofimatinibmesylateplasmalevelsandadversereactionsinchinesegistpatients AT tonghanxing geneticpolymorphismscontributetotheindividualvariationsofimatinibmesylateplasmalevelsandadversereactionsinchinesegistpatients AT zhouyuhong geneticpolymorphismscontributetotheindividualvariationsofimatinibmesylateplasmalevelsandadversereactionsinchinesegistpatients AT caiweimin geneticpolymorphismscontributetotheindividualvariationsofimatinibmesylateplasmalevelsandadversereactionsinchinesegistpatients |